Guotai SSE STAR Market Innovative Drugs ETF (589720) latest price of RMB 1.01, with its units growing by 173 million over the past week

NewTimeSpace (newtimespace.com) News, as of 11:02 on August 20, 2026, the SSE STAR Market Innovative Drugs Index (950161) surged 6.19%, and Guotai SSE STAR Market Innovative Drugs ETF (589720) had a latest price of RMB 1.01.

In terms of liquidity, the ETF's intraday turnover was 22.66%, with turnover value of RMB 1.048 billion, indicating active trading. Over a longer horizon, as of August 19, its average daily turnover over the past week was RMB 1.200 billion.

In terms of scale, the ETF's AUM grew by RMB 614 million over the past two weeks, achieving significant growth. (Source: Wind)

In terms of units, the ETF's units outstanding grew by 173 million over the past week, achieving significant growth. (Source: Wind)

In terms of fund inflows, the ETF's latest net capital outflow was RMB 148 million. Over a longer horizon, among the past 5 trading days, 3 saw net inflows, totaling RMB 313 million of accumulated net inflows ("capital attracted"), with an average daily net inflow of RMB 62.6947 million. (Source: Wind)

Data shows that leveraged funds continue to build positions. The ETF's margin financing net purchase amount month-to-date reached RMB 4.8198 million, and its latest margin financing balance reached RMB 402 million. (Source: Wind)

As of August 19, the ETF's net value has risen 7.26% over the past six months, ranking 772nd out of 4,902 index equity funds, placing it in the top 15.75%. In terms of return capability, as of August 19, 2026, since inception, the ETF's highest single-month return was 5.48%, its longest winning streak was 2 consecutive months with a cumulative gain of 6.23%, and its average return in rising months was 3.46%. As of August 19, 2026, the ETF's annualized excess return over the benchmark over the past three months was 3.15%.

In terms of drawdown, as of August 19, 2026, the ETF's drawdown relative to its benchmark over the past half year was 0.15%, the smallest drawdown among comparable funds, with a post-drawdown recovery of 25 days.

In terms of fees, the ETF's management fee rate is 0.50% and its custody fee rate is 0.10%, the lowest among comparable funds.

In terms of tracking accuracy, as of August 19, 2026, the ETF's tracking error year-to-date was 0.033%, the highest tracking accuracy among comparable funds.

Guotai SSE STAR Market Innovative Drugs ETF closely tracks the SSE STAR Market Innovative Drugs Index, which selects no more than 30 listed-company securities in the innovative-drugs field from the STAR Market as index constituents, aiming to reflect the overall performance of innovative-drugs listed-company securities on the STAR Market.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.